Let's Talk ID

Exploring Microbiome-Based Therapy

02.10.2024 - By Infectious Diseases Society of America (IDSA)Play

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Host Paul Sax, MD, FIDSA, is joined by Libby Hohmann, MD, FIDSA, an ID specialist at Massachusetts General Hospital, director of the Fecal Microbiota Transplant Lab and associate professor of medicine at Harvard Medical School, to discuss the innovative field of microbiome-based therapy, including the latest therapeutics, efficacy in treating COVID-19 and advice on treating patients with C. diff.

More episodes from Let's Talk ID